SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2022-06-23 15:49
Tx date 2022-06-22
$ACST
Acasti Pharma Inc.
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+165,000 vol
2,016,215
Filed 2021-11-15 14:26
Tx date 2021-11-12
$ACST
Acasti Pharma Inc.
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+287,900 vol
1,851,215
Filed 2020-04-01 15:45
Tx date 2020-03-31
$ACST
Acasti Pharma Inc.
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+587,000 vol
1,563,315
Filed 2019-04-15 13:59
Tx date 2019-04-15
$ACST
Acasti Pharma Inc.
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$448,000
+350,000 vol
$1.28 each
976,315
Filed 2018-07-04
Tx date 2018-07-02
$ACST
Acasti Pharma Inc.
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+365,515 vol
626,315
Filed 2017-06-16
Tx date 2017-06-14
$ACST
Acasti Pharma Inc.
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$164,610
+93,000 vol
$1.77 each
198,800
Filed 2017-06-16
Tx date 2017-06-14
$ACST
Acasti Pharma Inc.
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$274,350
+155,000 vol
$1.77 each
Filed 2017-06-15
Tx date 2017-06-14
$ACST
Acasti Pharma Inc.
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$109,740
+62,000 vol
$1.77 each
322,800
Filed 2017-06-15
Tx date 2017-06-14
$ACST
Acasti Pharma Inc.
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$274,350
+155,000 vol
$1.77 each
260,800
Filed 2017-04-13
Tx date 2017-04-11
$ACST
Acasti Pharma Inc.
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-315,000
-15,000 vol
$21.00 each
105,800
Filed 2017-03-01
Tx date 2017-02-24
$ACST
Acasti Pharma Inc.
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$82,500
+50,000 vol
$1.65 each
120,800
Filed 2016-06-21
Tx date 2016-06-16
$APO
Acasti Pharma Inc.
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-280,000
-20,000 vol
$14.00 each
70,800
Filed 2016-06-01
Tx date 2016-05-30
$APO
Acasti Pharma Inc.
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$62,486
+31,400 vol
$1.99 each
90,800
Filed 2015-12-09
Tx date 2013-12-03
$APO
Acasti Pharma Inc.
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Warrants (Units)
15 - Acquisition or disposition under a prospectus

+20,000 vol
Filed 2015-12-09
Tx date 2013-12-03
$APO
Acasti Pharma Inc.
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Warrants (Units)
15 - Acquisition or disposition under a prospectus

+20,000 vol
20,000
Filed 2015-12-09
Tx date 2013-12-03
$APO
Acasti Pharma Inc.
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Warrants (Units)
15 - Acquisition or disposition under a prospectus

+20,000 vol
Filed 2015-12-09
Tx date 2015-10-15
$APO
Acasti Pharma Inc.
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Warrants (Units)
37 - Stock split or consolidation

-18,000 vol
Filed 2015-12-09
Tx date 2013-12-03
$APO
Acasti Pharma Inc.
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Warrants (Units)
10 - Acquisition or disposition in the public market
$25,000
+20,000 vol
$1.25 each
Filed 2015-12-09
Tx date 2015-10-15
$APO
Acasti Pharma Inc.
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Warrants (Units)
37 - Stock split or consolidation

-18,000 vol
Filed 2015-11-03
Tx date 2015-10-15
$APO
Acasti Pharma Inc.
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation

-63,000 vol
7,000
Filed 2015-11-03
Tx date 2015-10-15
$APO
Acasti Pharma Inc.
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Warrants (Units)
37 - Stock split or consolidation

-18,000 vol
2,000
Filed 2015-11-03
Tx date 2015-10-15
$APO
Acasti Pharma Inc.
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-534,600 vol
59,400
Filed 2015-08-11
Tx date 2015-08-11
$NTB
Neptune Technologies & Bioressources Inc.
Lemieux, Pierre
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-2,256.15
-1,157 vol
$1.95 each
5
Filed 2015-07-17
Tx date 2015-07-16
$NTB
Neptune Technologies & Bioressources Inc.
Lemieux, Pierre
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-10,135
-6,250 vol
$1.62 each
1,162
Filed 2015-06-17
Tx date 2015-06-15
$APO
Acasti Pharma Inc.
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
57 - Exercise of rights
$4,500
+12,500 vol
$0.36 each
70,000
Filed 2015-06-17
Tx date 2015-06-15
$NTB
Neptune Technologies & Bioressources Inc.
Lemieux, Pierre
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
57 - Exercise of rights
$10,125
+6,250 vol
$1.62 each
7,412
Filed 2015-06-16
Tx date 2015-06-15
$NTB
Neptune Technologies & Bioressources Inc.
Lemieux, Pierre
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Restricted Share Units
57 - Exercise of rights
$-10,125
-6,250 vol
$1.62 each
0
Filed 2015-06-16
Tx date 2015-06-15
$APO
Acasti Pharma Inc.
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
$-4,500
-12,500 vol
$0.36 each
0
Filed 2015-06-08
Tx date 2015-06-01
$APO
Acasti Pharma Inc.
Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$76,050
+169,000 vol
$0.45 each
594,000